Dexamethason Zentiva 5 mg Soluzione iniettabile

Country: Շվեյցարիա

language: իտալերեն

source: Swissmedic (Swiss Agency for Therapeutic Products)

buyitnow

PIL PIL (PIL)
16-05-2024
SPC SPC (SPC)
16-05-2024

active_ingredient:

dexamethasoni natrii phosphas, dexamethasonum

MAH:

Helvepharm AG

ATC_code:

H02AB02

INN:

dexamethasoni natrii phosphas, dexamethasonum

pharmaceutical_form:

Soluzione iniettabile

composition:

dexamethasoni natrii phosphas 5 mg corresp. dexamethasonum 3.8 mg, dinatrii edetas, natrii citras dihydricus, glycerolum, antiox.: E 223 1 mg, conserv.: alcohol benzylicus 10.5 mg, aqua ad iniectabile q.s. ad solutionem pro 1 ml.

class:

B

therapeutic_group:

Synthetika

therapeutic_area:

Glukokortikosteroid-Therapie

authorization_status:

zugelassen

authorization_date:

1977-11-30

documents_in_other_languages

SPC SPC գերմաներեն 24-10-2018
PIL PIL ֆրանսերեն 16-05-2024
SPC SPC ֆրանսերեն 01-07-2022